| Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations S Hamdy, A Haddadi, RW Hung, A Lavasanifar Advanced drug delivery reviews 63 (10-11), 943-955, 2011 | 371 | 2011 |
| Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile P Rafiei, A Haddadi International journal of nanomedicine, 935-947, 2017 | 304 | 2017 |
| Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity S Hamdy, O Molavi, Z Ma, A Haddadi, A Alshamsan, Z Gobti, S Elhasi, ... Vaccine 26 (39), 5046-5057, 2008 | 301 | 2008 |
| Micelles of poly(ethylene oxide)‐b‐poly(ε‐caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin Z Ma, A Haddadi, O Molavi, A Lavasanifar, R Lai, J Samuel Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2008 | 251 | 2008 |
| Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine A Alshamsan, A Haddadi, V Incani, J Samuel, A Lavasanifar, H Uludag Molecular pharmaceutics 6 (1), 121-133, 2009 | 202 | 2009 |
| Effects of Size and Surface Charge of Polymeric Nanoparticles on in Vitro and in Vivo Applications SMA Sadat, ST Jahan, A Haddadi Journal of Biomaterials and Nanobiotechnology 7 (02), 91, 2016 | 185 | 2016 |
| Targeted therapeutic nanoparticles: an immense promise to fight against cancer ST Jahan, SMA Sadat, M Walliser, A Haddadi Journal of drug delivery 2017 (1), 9090325, 2017 | 132 | 2017 |
| Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles S Hamdy, A Haddadi, A Shayeganpour, J Samuel, A Lavasanifar Pharmaceutical research 28, 2288-2301, 2011 | 124 | 2011 |
| Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells A Haddadi, P Elamanchili, A Lavasanifar, S Das, J Shapiro, J Samuel Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2008 | 116 | 2008 |
| STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response A Alshamsan, A Haddadi, S Hamdy, J Samuel, AOS El-Kadi, H Uludag, ... Molecular pharmaceutics 7 (5), 1643-1654, 2010 | 113 | 2010 |
| Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles Z Ghotbi, A Haddadi, S Hamdy, RW Hung, J Samuel, A Lavasanifar Journal of drug targeting 19 (4), 281-292, 2011 | 93 | 2011 |
| Resveratrol analog trans 3, 4, 5, 4′-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol Z Ma, O Molavi, A Haddadi, R Lai, RA Gossage, A Lavasanifar Cancer chemotherapy and pharmacology 63, 27-35, 2008 | 84 | 2008 |
| Prospects for RNAi therapy of COVID-19 H Uludağ, K Parent, HM Aliabadi, A Haddadi Frontiers in Bioengineering and Biotechnology 8, 916, 2020 | 79 | 2020 |
| A robust systematic design: optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery P Rafiei, A Haddadi Materials Science and Engineering: C 104, 109950, 2019 | 64 | 2019 |
| Delivery of rapamycin‐loaded nanoparticle down regulates ICAM‐1 expression and maintains an immunosuppressive profile in human CD34+ progenitor‐derived … S Das, A Haddadi, S Veniamin, J Samuel Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2008 | 51 | 2008 |
| Pharmaceutical analysis of synthetic lipid A-based vaccine adjuvants in poly (d,l-lactic-co-glycolic acid) nanoparticle formulations S Hamdy, A Haddadi, V Somayaji, D Ruan, J Samuel Journal of pharmaceutical and biomedical analysis 44 (4), 914-923, 2007 | 51 | 2007 |
| STAT3 knockdown in B16 melanoma by siRNA lipopolyplexes induces bystander immune response in vitro and in vivo A Alshamsan, S Hamdy, A Haddadi, J Samuel, AOS El-Kadi, H Uludağ, ... Translational oncology 4 (3), 178-188, 2011 | 47 | 2011 |
| Nano-pharmaceutical formulations for targeted drug delivery against HER2 in breast cancer S MA Sadat, S Saeidnia, A J. Nazarali, A Haddadi Current cancer drug targets 15 (1), 71-86, 2015 | 42 | 2015 |
| Pharmacokinetic consequences of PLGA nanoparticles in docetaxel drug delivery P Rafiei, A Haddadi Pharmaceutical Nanotechnology 5 (1), 3-23, 2017 | 37 | 2017 |
| Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles ST Jahan, A Haddadi International journal of nanomedicine, 7371-7384, 2015 | 37 | 2015 |
Soodabeh SaeidniaAssociate Professor (Pharm.D., Ph.D.)Verified email at tums.ac.ir
